Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesoblast (MESO) Cash & Current Investments: 2015-2025

Historic Cash & Current Investments for Mesoblast (MESO) over the last 11 years, with Jun 2025 value amounting to $161.6 million.

  • Mesoblast's Cash & Current Investments rose 156.67% to $161.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $358.8 million, marking a year-over-year increase of 34.88%. This contributed to the annual value of $161.6 million for FY2025, which is 156.67% up from last year.
  • As of FY2025, Mesoblast's Cash & Current Investments stood at $161.6 million, which was up 156.67% from $63.0 million recorded in FY2024.
  • Mesoblast's 5-year Cash & Current Investments high stood at $161.6 million for FY2025, and its period low was $60.4 million during FY2022.
  • In the last 3 years, Mesoblast's Cash & Current Investments had a median value of $71.3 million in 2023 and averaged $98.6 million.
  • As far as peak fluctuations go, Mesoblast's Cash & Current Investments tumbled by 55.84% in 2022, and later soared by 156.67% in 2025.
  • Yearly analysis of 5 years shows Mesoblast's Cash & Current Investments stood at $136.9 million in 2021, then slumped by 55.84% to $60.4 million in 2022, then grew by 17.98% to $71.3 million in 2023, then dropped by 11.72% to $63.0 million in 2024, then soared by 156.67% to $161.6 million in 2025.